Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Psychiatry Research (2024) Vol. 335, pp. 115880-115880
Closed Access | Times Cited: 14

Showing 14 citing articles:

Adverse Events in Studies of Classic Psychedelics
Jared T. Hinkle, Marianna Graziosi, Sandeep M. Nayak, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 26
A framework for assessment of adverse events occurring in psychedelic-assisted therapies
Roman Palitsky, Deanna M. Kaplan, John Perna, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 690-700
Closed Access | Times Cited: 14
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access | Times Cited: 1
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement
Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e095992-e095992
Open Access
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes
Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz, et al.
Neuropharmacology (2025), pp. 110402-110402
Closed Access
Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations
Blerida Banushi, Jemma Collova, Helen Milroy
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3075-3075
Open Access
Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
Clémentine Estric, Thomas Duron, Sarah Kabani, et al.
Journal of Psychopharmacology (2025)
Closed Access
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 3
Leveraging meditation research for the study of psychedelic-related adverse effects
Roman Palitsky, Nicholas K. Canby, Nicholas T. Van Dam, et al.
International Review of Psychiatry (2024), pp. 1-15
Closed Access | Times Cited: 3
Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 755-757
Open Access | Times Cited: 1
Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA
Abigail E. Calder, Gregor Hasler
(2024)
Open Access | Times Cited: 1
Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions
Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Psychedelic‐assisted therapy for palliative care within a home treatment setting: A case report
Federico Seragnoli, Martignoni Geo, Martignoni Entela, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 9
Open Access
Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions
Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, et al.
International journal of medicinal mushrooms (2024) Vol. 27, Iss. 2, pp. 13-37
Closed Access
Page 1

Scroll to top